Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

NCT01523977

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

NCT01660451

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Birmingham, Alabama, United States
  • Gilbert, Arizona, United States
  • Anaheim, California, United States
  • Aurora, Colorado, United States
View all 102 locations
View Trial Details
Completed

Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma

NCT01472562

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Weill Cornell Medical College New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00557193

Conditions
Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 170 locations
View Trial Details
Completed

A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

NCT03942263

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • State budgetary healthcare institution of the Astrakhan region Alexander-Mariinsky regional clinical hospital Astrakhan, Russia
  • Autonomous Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of Chuvashia Cheboksary, Russia
  • State budgetary health care institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine" Chelyabinsk, Russia
  • State Budget Public Health Institution "Regional Oncological Dispensary" Irkutsk, Russia
View all 50 locations
View Trial Details
Completed

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

NCT02654990

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Novartis Investigative Site Fayetteville, Arkansas, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Fort Collins, Colorado, United States
  • Novartis Investigative Site Gainesville, Florida, United States
View all 80 locations
View Trial Details

Related conditions